awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26824877-522E8134-3CE0-4C5E-B89D-35A7C22E9150
Q26824877-522E8134-3CE0-4C5E-B89D-35A7C22E9150
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824877-522E8134-3CE0-4C5E-B89D-35A7C22E9150
Combating acquired resistance to tyrosine kinase inhibitors in lung cancer
P2860
Q26824877-522E8134-3CE0-4C5E-B89D-35A7C22E9150
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824877-522E8134-3CE0-4C5E-B89D-35A7C22E9150
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c4244bc24c6c52e475c9cafa48224c13a268c270
P2860
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study.